Package 47426-201-01

{"route": ["INTRAVENOUS"], "spl_id": "276ea381-d554-4e61-8511-39e6fd8291d6", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "unii": ["1NF15YR6UY"], "rxcui": ["1995150", "1995155"], "spl_set_id": ["4c218d3a-a508-4abc-9ed8-a6e8e191d1b4"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Heron Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (47426-201-01)  / 18 mL in 1 VIAL, GLASS", "package_ndc": "47426-201-01", "marketing_start_date": "20180103"}], "brand_name": "CINVANTI", "product_id": "47426-201_276ea381-d554-4e61-8511-39e6fd8291d6", "dosage_form": "INJECTION, EMULSION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "47426-201", "generic_name": "aprepitant", "labeler_name": "Heron Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CINVANTI", "active_ingredients": [{"name": "APREPITANT", "strength": "130 mg/18mL"}], "application_number": "NDA209296", "marketing_category": "NDA", "marketing_start_date": "20180103", "listing_expiration_date": "20261231"}